A. Ohtahara

发表

Increased double product on Monday morning during work

K. Nagatoya, M. Munakata, G. Kimura, 2017, Hypertension Research.

Plasma levels of uridine correlate with blood pressure and indicators of myogenic purine degradation and insulin resistance in hypertensive patients.

I. Hisatome, Tetsuya Yamamoto, S. Sugihara, 2007, Circulation journal : official journal of the Japanese Circulation Society.

Prevalence and complications of hypouricemia in a general population: A large-scale cross-sectional study in Japan

I. Hisatome, K. Niwa, M. Kuwabara, 2017, PloS one.

Hospital End User Computing in Japan: How to Use FileMaker Pro with Hospital Information Systems

Shinsuke Hiramatsu, Hiroyuki Yoshihara, Yasuhito Yamamoto, 2018 .

Japanese Society of Gout and Uric & Nucleic Acids 2019 Guidelines for Management of Hyperuricemia and Gout 3rd edition

Y. Moriwaki, A. Taniguchi, I. Hisatome, 2020 .

Effects of Cilnidipine on Serum Uric Acid Level and Urinary Nitrogen Monoxide Excretion in Patients with Hypertension

I. Hisatome, K. Yamada, Masahiko Kato, 2012, Clinical and experimental hypertension.

[Clinical incidence of primary cardiac tumors].

A. Endo, H. Mashiba, C. Shigemasa, 1996, Journal of cardiology.

A comparative study on the effectiveness of losartan/hydrochlorothiazide and telmisartan/hydrochlorothiazide in patients with hypertension

I. Hisatome, Masahiko Kato, Kazuhiro Yamamoto, 2014, Clinical and experimental hypertension.

Uricosuric action of losartan via the inhibition of urate transporter 1 (URAT 1) in hypertensive patients.

I. Hisatome, S. Sugihara, T. Hosoya, 2008, American journal of hypertension.

Characteristics of 161 patients with cardiac tumors diagnosed during 1993 and 1994 in Japan.

A. Endo, H. Mashiba, C. Shigemasa, 1997, The American journal of cardiology.

Novel inhibitory effects of dotinurad, a selective urate reabsorption inhibitor, on urate crystal-induced activation of NLRP3 inflammasomes in macrophages

I. Hisatome, Tetsuya Yamamoto, S. Sugihara, 2020 .

[Clinical features of coronary artery ectasia].

K. Sonoyama, Y. Furuse, T. Kasahara, 2004, Journal of cardiology.

Mechanism of inhibition of the sodium current by bepridil in guinea‐pig isolated ventricular cells

I. Hisatome, R. Sato, H. Kotake, 1995, British journal of pharmacology.

Mitochondrial DNA deletion associated with the reduction of adenine nucleotides in human atrium and atrial fibrillation

M. Shimoyama, I. Hisatome, E. Nanba, 2001, European journal of clinical investigation.

The release of the substrate for xanthine oxidase in hypertensive patients was suppressed by angiotensin converting enzyme inhibitors and α1-blockers

I. Hisatome, T. Yamamoto, M. Watanabe, 2001, Journal of hypertension.

Enhanced activity of the purine nucleotide cycle of the exercising muscle in patients with hyperthyroidism.

I. Hisatome, H. Fukui, C. Shigemasa, 2001, The Journal of clinical endocrinology and metabolism.

Effect of Antihypertensive Drugs on Uric Acid Metabolism in Patients with Hypertension: Cross-Sectional Cohort Study

I. Hisatome, S. Ueno, F. Taufiq, 2016, Drug Research.

Effect of the angiotensin II receptor antagonist losartan on uric acid and oxypurine metabolism in healthy subjects.

I. Hisatome, Tetsuya Yamamoto, Y. Kinugasa, 2002, Internal medicine.

Control of AMP deaminase 1 binding to myosin heavy chain.

I. Hisatome, T. Morisaki, H. Morisaki, 1998, American journal of physiology. Cell physiology.

Control of AMP deaminase 1 binding to myosin heavy chain.

I. Hisatome, T. Morisaki, H. Morisaki, 1998, The American journal of physiology.

Clinical practice guideline for renal hypouricemia (1st edition)

I. Hisatome, N. Shinomiya, K. Ogino, 2019, Human Cell.

A novel mutation causing complete deficiency of thyroxine binding globulin

I. Hisatome, I. Manabe, S. Taniguchi, 1997, Clinical endocrinology.

Acute secondary gastrointestinal amyloidosis in a patient with rheumatoid arthritis.

M. Shimoyama, I. Hisatome, Y. Ueda, 2003, The American journal of the medical sciences.

Effects of azelnidipine on uric acid metabolism in patients with essential hypertension

Y. Moriwaki, Jidong Cheng, I. Hisatome, 2014, Clinical and experimental hypertension.

Evaluation of changes in sympathetic nerve activity and heart rate in essential hypertensive patients induced by amlodipine and nifedipine

I. Hisatome, T. Kaneda, C. Shigemasa, 1998, Journal of hypertension.

A Vasodilating β1 Blocker Celiprolol Inhibits Muscular Release of Uric Acid Precursor in Patients with Essential Hypertension

I. Hisatome, K. Yamada, M. Mishima, 2012, Hormone and Metabolic Research.

Xanthinuria Type 1 with a Novel Mutation in Xanthine Dehydrogenase and a Normal Endothelial Function

I. Hisatome, S. Sugihara, M. Kuwabara, 2022, Internal medicine.

Characteristics of cardiac myxoma with constitutional signs: A multicenter study in Japan

I. Hisatome, A. Endo, K. Ogino, 2002, Clinical cardiology.

Expression of Shaker-type voltage-gated potassium channel genes in the guinea-pig.

I. Hisatome, I. Manabe, G. Ahmmed, 1998, Research communications in molecular pathology and pharmacology.

A new type of familial central diabetes insipidus caused by a single base substitution in the neurophysin II coding region of the vasopressin gene.

I. Hisatome, E. Nanba, I. Manabe, 1996, The Journal of clinical endocrinology and metabolism.

Renal handling of urate in a patient with familial juvenile gouty nephropathy.

I. Hisatome, I. Manabe, C. Shigemasa, 1996, Internal medicine.

Effects of Irbesartan on Uric Acid Metabolism in Patients with Treated Essential Hypertension

I. Hisatome, S. Sugihara, Masahiko Kato, 2018 .

CARDIOVASCULAR EFFECTS OF INTRACEREBROVENTRICULARLY ADMINISTERED GROWTH HORMONE‐RELEASING FACTOR IN SPONTANEOUSLY HYPERTENSIVE RAT

M. Watanabe, T. Kaneda, H. Mashiba, 1995, Clinical and experimental pharmacology & physiology. Supplement.

Vascular Failure

I. Hisatome, S. Sugihara, Masahiko Kato, 2020 .